Screener
iRadimed IRMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue, non-current | 3,757 | 3,978 |
| Total liabilities | $15,875 | 14,158 |
| Stockholders’ equity: | ||
| Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,782,837 shares issued and outstanding as of March 31, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025 | $1 | $1 |
| Additional paid-in capital | 31,020 | 30,386 |
| Retained earnings | 67,493 | 64,231 |
| Total stockholders' equity | 98,514 | 94,618 |
| Total liabilities and stockholders’ equity | $114,389 | $108,776 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's common stock, par value (in dollars per share)?
- iRadimed (IRMD) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
Ask your AI about iRadimed's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude